United States logged 1 verified funding round in the week ending 28 Dec 2014, totalling ≈$9.0M. Novira Therapeutics anchors the week with a ≈$9.0M Series A in Hospitals and Health Care.
| Country | United States |
| Deals this week | 1 |
| Total raised | ≈$9.0M |
| Top sector | Hospitals and Health Care (1) |
| Most common round | Series A (1) |
| Sources tracked | 3 |
| # | Company | Amount | Round | Sector | Announced |
|---|---|---|---|---|---|
| 1 | Novira Therapeutics | $9.0M | Series A | Hospitals and Health Care | 24 Dec 2014 |
Novira Therapeutics$9.0M · Series A · Hospitals and Health Care · United States
Novira is an antiviral drug discovery company launched in 2009 that is focused on the discovery of novel, first-in-class therapeutics for the treatment of HBV and HIV, two global diseases in need of better therapies.
2 more sources tracked. Read the full press release and reporter coverage.
Sign up to read →Hospitals and Health Care accounted for 1 of 1 verified deals in United States this week. The stage mix was 0 early-stage (pre-seed to seed) against 1 Series A or later.
